Cargando…
Gamma-Secretase Inhibitor, DAPT, Prevents the Development of Retinopathy of Prematurity in a Rat Model by Regulating the Delta-Like Ligand 4/Notch Homolog-1 (DLL4/Notch-1) Pathway
BACKGROUND: Retinopathy of prematurity (ROP), or retrolental fibroplasia, affects premature infants who have undergone intensive care with oxygen therapy. This study aimed to investigate the inhibitory effect of the gamma-secretase inhibitor, DAPT, on neovascularization and its mechanism in a rat mo...
Autores principales: | Sun, Wei, Li, Jing, Li, Yinan, Zheng, Jiao, Zhang, Xiaoming, Huang, Xuelin, Li, Shujun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6345111/ https://www.ncbi.nlm.nih.gov/pubmed/30652694 http://dx.doi.org/10.12659/MSM.913828 |
Ejemplares similares
-
The ectodomains determine ligand function in vivo and selectivity of DLL1 and DLL4 toward NOTCH1 and NOTCH2 in vitro
por: Tveriakhina, Lena, et al.
Publicado: (2018) -
Context-Dependent Functional Divergence of the Notch Ligands DLL1 and DLL4 In Vivo
por: Preuße, Kristina, et al.
Publicado: (2015) -
γ‐secretase inhibitor DAPT mitigates cisplatin‐induced acute kidney injury by suppressing Notch1 signaling
por: Soni, Hitesh, et al.
Publicado: (2018) -
Therapeutic promise and challenges of targeting DLL4/NOTCH1
por: Yan, Minhong
Publicado: (2011) -
The Notch ligand Delta-like 4 (DLL4) as a target in angiogenesis-based cancer therapy?
por: Brzozowa, Marlena, et al.
Publicado: (2013)